epocrates logo
epocrates logo
epocrates logo
  • 0

Interaction Check

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

  • remove lamotrigine
    generic
  • remove Orsythia
    levonorgestrel/ ethinyl estradiol

multicheck MultiCheck Results - 1 Interaction

Smiley face Smiley face

Monitor/Modify Tx

Smiley face Smiley face lamotrigine (generic) + Orsythia (levonorgestrel/ ethinyl estradiol)

Monitor/Modify Tx


lamotrigine + ethinyl estradiol (contraceptive)

consider gradual incr. of lamotrigine maint. dose up to 2-fold, initial dose escalation unchanged; no change if also on carbamazepine, phenytoin, phenobarbital, primidone, rifampin, or ritonavir: combo may decr. lamotrigine levels, efficacy; transient incr. of lamotrigine levels, adverse effects may occur during inert tab phase (UGT induced)

Additional Considerations

Smiley face Smiley face lamotrigine

caution advised with other sodium channel blockers; combo may increase risk of ECG changes, cardiac arrhythmias; additive effects

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information